Skip to content

Renegade™ STC 18 M001181270Recalls & reported problems

Boston Scientific Corporation · Microcatheter · Class 2

All models of Renegade STC 18 (7)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08714729444404), received between Oct 17, 2018 and Feb 7, 2024 — classified as 3 malfunctions.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 1 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Break1
  • Material Integrity Problem1
  • Material Split, Cut or Torn1

Patient problems

  • No Consequences Or Impact To Patient2
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 7, 2024Material Integrity Problem; Material Integrity Problem

    IT WAS REPORTED THAT CATHETER WAS PUNCTURED. A RENEGADE STC 18 WAS SELECTED FOR USE IN A SEVERELY CALCIFIED VESSEL. DURING THE PROCEDURE, UPON INSERTION OF THE GUIDEWIRE, IT WAS NOTED THAT THE CATHETER WAS PUNCTURED. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED, AND THE PATIENT WAS FINE POST PROCEDURE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18664167 ↗
  • MalfunctionSep 10, 2020Break; Break

    IT WAS REPORTED THAT THE MICROCATHETER WAS FRACTURED. A RENEGADE STC-18 MICROCATHETER WAS SELECTED FOR USE. DURING THE PROCEDURE, INTRODUCING THE MICROCATHETER WAS SMOOTH. HOWEVER, WHEN THE CHEMO-DRUG WAS INJECTED, THE PHYSICIAN FOUND THAT THE FLOW OF THE DRUG WAS ABNORMAL AND DID NOT GO TOWARD THE TARGET VESSEL UNDER ANGIOGRAM. SO, HE REMOVED THE MICROCATHETER WITHOUT FRICTION AND TESTED IT OUTSIDE OF THE PATIENT'S BODY. THEN, HE FOUND A FRACTURE IN THE DISTAL OF THE MICROCATHETER. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. NO COMPLICATIONS WERE REPORTED AND THE PATIENT WAS STABLE POST PROCEDURE.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 10514737 ↗
  • MalfunctionOct 17, 2018Material Split, Cut or Torn; Material Split, Cut or Torn

    IT WAS REPORTED THAT THE CATHETER WAS TORN. A 105/20 RENEGADE STC 18 WAS SELECTED FOR USE. DURING UNPACKING, IT WAS OBSERVED THAT THERE WAS SOME KIND OF A TEAR IN THE CATHETER. DEVICE WAS NEVER USED AND THE PROCEDURE WAS COMPLETED USING ANOTHER OF THE SAME DEVICE. NO PATIENT INVOLVEMENT.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7973673 ↗

Other CATHETER, INTRAVASCULAR, DIAGNOSTIC devices

All CATHETER, INTRAVASCULAR, DIAGNOSTIC devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page